Lsh/HELLS is required for B lymphocyte development and immunoglobulin class switch recombination. 2020

Yafeng He, and Jianke Ren, and Xiaoping Xu, and Kai Ni, and Andrew Schwader, and Richard Finney, and Can Wang, and Lei Sun, and Kimberly Klarmann, and Jonathan Keller, and Anthony Tubbs, and Andre Nussenzweig, and Kathrin Muegge
Epigenetics Section, Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702.

Mutation of HELLS (Helicase, Lymphoid-Specific)/Lsh in human DNA causes a severe immunodeficiency syndrome, but the nature of the defect remains unknown. We assessed here the role of Lsh in hematopoiesis using conditional Lsh knockout mice with expression of Mx1 or Vav Cre-recombinase. Bone marrow transplantation studies revealed that Lsh depletion in hematopoietic stem cells severely reduced B cell numbers and impaired B cell development in a hematopoietic cell-autonomous manner. Lsh-deficient mice without bone marrow transplantation exhibited lower Ig levels in vivo compared to controls despite normal peripheral B cell numbers. Purified B lymphocytes proliferated normally but produced less immunoglobulins in response to in vitro stimulation, indicating a reduced capacity to undergo class switch recombination (CSR). Analysis of germline transcripts, examination of double-stranded breaks using biotin-labeling DNA break assay, and End-seq analysis indicated that the initiation of the recombination process was unscathed. In contrast, digestion-circularization PCR analysis and high-throughput sequencing analyses of CSR junctions and a chromosomal break repair assay indicated an impaired ability of the canonical end-joining pathway in Lsh-deficient B cells. Our data suggest a hematopoietic cell-intrinsic role of Lsh in B cell development and in CSR providing a potential target for immunodeficiency therapy.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004265 DNA Helicases Proteins that catalyze the unwinding of duplex DNA during replication by binding cooperatively to single-stranded regions of DNA or to short regions of duplex DNA that are undergoing transient opening. In addition, DNA helicases are DNA-dependent ATPases that harness the free energy of ATP hydrolysis to translocate DNA strands. ATP-Dependent DNA Helicase,DNA Helicase,DNA Unwinding Protein,DNA Unwinding Proteins,ATP-Dependent DNA Helicases,DNA Helicase A,DNA Helicase E,DNA Helicase II,DNA Helicase III,ATP Dependent DNA Helicase,ATP Dependent DNA Helicases,DNA Helicase, ATP-Dependent,DNA Helicases, ATP-Dependent,Helicase, ATP-Dependent DNA,Helicase, DNA,Helicases, ATP-Dependent DNA,Helicases, DNA,Protein, DNA Unwinding,Unwinding Protein, DNA,Unwinding Proteins, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018345 Mice, Knockout Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes. Knockout Mice,Mice, Knock-out,Mouse, Knockout,Knock-out Mice,Knockout Mouse,Mice, Knock out
D020868 Gene Silencing Interruption or suppression of the expression of a gene at transcriptional or translational levels. Gene Inactivation,Inactivation, Gene,Silencing, Gene

Related Publications

Yafeng He, and Jianke Ren, and Xiaoping Xu, and Kai Ni, and Andrew Schwader, and Richard Finney, and Can Wang, and Lei Sun, and Kimberly Klarmann, and Jonathan Keller, and Anthony Tubbs, and Andre Nussenzweig, and Kathrin Muegge
November 2010, The Journal of biological chemistry,
Yafeng He, and Jianke Ren, and Xiaoping Xu, and Kai Ni, and Andrew Schwader, and Richard Finney, and Can Wang, and Lei Sun, and Kimberly Klarmann, and Jonathan Keller, and Anthony Tubbs, and Andre Nussenzweig, and Kathrin Muegge
May 2004, The Journal of cell biology,
Yafeng He, and Jianke Ren, and Xiaoping Xu, and Kai Ni, and Andrew Schwader, and Richard Finney, and Can Wang, and Lei Sun, and Kimberly Klarmann, and Jonathan Keller, and Anthony Tubbs, and Andre Nussenzweig, and Kathrin Muegge
January 1993, Annual review of immunology,
Yafeng He, and Jianke Ren, and Xiaoping Xu, and Kai Ni, and Andrew Schwader, and Richard Finney, and Can Wang, and Lei Sun, and Kimberly Klarmann, and Jonathan Keller, and Anthony Tubbs, and Andre Nussenzweig, and Kathrin Muegge
March 2009, The Journal of biological chemistry,
Yafeng He, and Jianke Ren, and Xiaoping Xu, and Kai Ni, and Andrew Schwader, and Richard Finney, and Can Wang, and Lei Sun, and Kimberly Klarmann, and Jonathan Keller, and Anthony Tubbs, and Andre Nussenzweig, and Kathrin Muegge
May 2010, Clinical immunology (Orlando, Fla.),
Yafeng He, and Jianke Ren, and Xiaoping Xu, and Kai Ni, and Andrew Schwader, and Richard Finney, and Can Wang, and Lei Sun, and Kimberly Klarmann, and Jonathan Keller, and Anthony Tubbs, and Andre Nussenzweig, and Kathrin Muegge
July 2012, Arthritis research & therapy,
Yafeng He, and Jianke Ren, and Xiaoping Xu, and Kai Ni, and Andrew Schwader, and Richard Finney, and Can Wang, and Lei Sun, and Kimberly Klarmann, and Jonathan Keller, and Anthony Tubbs, and Andre Nussenzweig, and Kathrin Muegge
January 2007, European journal of immunology,
Yafeng He, and Jianke Ren, and Xiaoping Xu, and Kai Ni, and Andrew Schwader, and Richard Finney, and Can Wang, and Lei Sun, and Kimberly Klarmann, and Jonathan Keller, and Anthony Tubbs, and Andre Nussenzweig, and Kathrin Muegge
November 2004, The Journal of experimental medicine,
Yafeng He, and Jianke Ren, and Xiaoping Xu, and Kai Ni, and Andrew Schwader, and Richard Finney, and Can Wang, and Lei Sun, and Kimberly Klarmann, and Jonathan Keller, and Anthony Tubbs, and Andre Nussenzweig, and Kathrin Muegge
August 2009, International immunology,
Yafeng He, and Jianke Ren, and Xiaoping Xu, and Kai Ni, and Andrew Schwader, and Richard Finney, and Can Wang, and Lei Sun, and Kimberly Klarmann, and Jonathan Keller, and Anthony Tubbs, and Andre Nussenzweig, and Kathrin Muegge
November 2021, eLife,
Copied contents to your clipboard!